A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Metformin mechanism of action





Metformin - Wikipedia, the free encyclopedia

10/24/2014
06:34 | Author: Evan Martin

Metformin mechanism of action
Metformin - Wikipedia, the free encyclopedia

Metformin is an oral antidiabetic drug in the biguanide class. It is the first-line drug of choice for the treatment of type 2.

Metformin has also been reported to decrease the blood levels of thyroid-stimulating hormone in people with hypothyroidism, The clinical significance of this is still unknown.

A 2007 systematic review of controlled trials, however, suggested metformin is the only antidiabetic drug not associated with any measurable harm in people with heart failure, and it may reduce mortality in comparison with other antidiabetic agents. Metformin is contraindicated in people with any condition that could increase the risk of lactic acidosis, including kidney disorders ( creatinine levels over 150 μmol/l (1.7 mg/dl), although this is an arbitrary limit), lung disease and liver disease.

Comments (1)Read more



Glucophage, Glucophage XR (Metformin Hcl) Drug Information

12/23/2014
04:08 | Author: Evan Martin

Metformin mechanism of action
Glucophage, Glucophage XR (Metformin Hcl) Drug Information

Its pharmacologic mechanisms of action are different from other classes of oral antihyperglycemic agents. Metformin decreases hepatic glucose production.

Here is a collection of user reviews for the medication Glucophage, Glucophage XR sorted by most helpful.

In patients with decreased renal function (based on measured creatinine clearance), the plasma and blood half-life of metformin is prolonged and the renal clearance is decreased in proportion to the decrease in creatinine clearance (see Table 1; also see WARNINGS ).

Metformin Gets Highest Marks in Diabetes Study »

Changes in lipid parameters in the previously described placebo-controlled dose-response study of GLUCOPHAGE XR are shown in Table 8.

Patients entering the study had a mean baseline HbA1c of 8.0% and a mean baseline FPG of 176 mg/dL.

Comments (2)Read more

Molecular mechanism of action of metformin old or new insights?

10/22/2014
02:38 | Author: Caitlin White

Metformin mechanism of action
Molecular mechanism of action of metformin old or new insights?

Metformin was discovered before the era of target-based drug discovery and its molecular mechanism of action remains an area of vigorous.

They found that metformin-induced AMPK activation was profoundly reduced in Lkb1 knockout liver and that, strikingly, metformin treatment failed to produce a glucose-lowering effect in liver-specific Lkb1 knockout mice rendered hyperglycaemic (by feeding these mice a fat-enriched diet). Shaw et al proposed that the LKB1–AMPK signalling controls the expression of key gluconeogenic genes via the regulation of a transcription coactivator, namely, cAMP response element-binding protein-regulated transcription coactivator 2 (CRTC2).

Comments (3)Read more

Metforminmdashmode of action and clinical implications for

8/21/2014
12:04 | Author: Devin Garcia

Mechanism of action in pharmacology
Metforminmdashmode of action and clinical implications for

The centre of metformin's mechanism of action is the alteration of the energy metabolism of the cell. Metformin exerts its prevailing.

Comments (0)

DrugBank Metformin (DB00331)

6/20/2014
02:10 | Author: Caitlin White

Metformin mechanism of action
DrugBank Metformin (DB00331)

Metformin may induce weight loss and is the drug of choice for. Mechanism of action, Metformin's mechanisms of action differ from other.

Kind: protein Organism: Human Pharmacological action: yes Actions: inducer Kind: protein Organism: Human Pharmacological action: unknown Actions: substrate inhibitor Kind: protein Organism: Human Pharmacological action: unknown Actions: substrate inhibitor Kind: protein Organism: Human Pharmacological action: unknown Actions: substrate Kind: protein Organism: Human Pharmacological action: unknown Actions: inhibitor Kind: protein Organism: Human Pharmacological action: unknown Actions: substrate. Jorn Moeckel, Rolf-Dieter Gabel, Heinrich Woog, “Pharmaceutical preparation containing metformin and a process for producing it.” U.S.

Comments (5)Read more